Your browser doesn't support javascript.
loading
Time to First Culture Positivity for Gram-Negative Rods Resistant to Ceftriaxone in Critically Ill Adults.
Buell, Kevin G; Casey, Jonathan D; Noto, Michael J; Rice, Todd W; Semler, Matthew W; Stollings, Joanna L.
Afiliación
  • Buell KG; Department of Internal Medicine, 12328Vanderbilt University Medical Center, Nashville, TN, USA.
  • Casey JD; Division of Allergy, Pulmonary, and Critical Care Medicine, 12328Vanderbilt University Medical Center, Nashville, TN, USA.
  • Noto MJ; Division of Allergy, Pulmonary, and Critical Care Medicine, 12328Vanderbilt University Medical Center, Nashville, TN, USA.
  • Rice TW; Division of Allergy, Pulmonary, and Critical Care Medicine, 12328Vanderbilt University Medical Center, Nashville, TN, USA.
  • Semler MW; Division of Allergy, Pulmonary, and Critical Care Medicine, 12328Vanderbilt University Medical Center, Nashville, TN, USA.
  • Stollings JL; Department of Pharmaceutical Services, 12328Vanderbilt University Medical Center, Nashville, TN, USA.
J Intensive Care Med ; 36(1): 51-57, 2021 Jan.
Article en En | MEDLINE | ID: mdl-33016193

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ceftriaxona / Enfermedad Crítica / Farmacorresistencia Bacteriana / Bacterias Gramnegativas / Antibacterianos Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: J Intensive Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ceftriaxona / Enfermedad Crítica / Farmacorresistencia Bacteriana / Bacterias Gramnegativas / Antibacterianos Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: J Intensive Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
...